ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 179 filers reported holding ARCUS BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is 2.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $143,600 | -88.2% | 8,000 | -86.7% | 0.00% | -90.9% |
| Q2 2023 | $1,218,600 | -55.2% | 60,000 | -59.7% | 0.02% | -57.7% |
| Q1 2023 | $2,717,760 | +5375.8% | 149,000 | +6108.3% | 0.05% | +5100.0% |
| Q4 2022 | $49,632 | -99.5% | 2,400 | -99.4% | 0.00% | -99.3% |
| Q2 2022 | $10,425,000 | +125.7% | 411,400 | +181.1% | 0.14% | +155.4% |
| Q1 2022 | $4,619,000 | +315.8% | 146,340 | +225.9% | 0.06% | +51.4% |
| Q2 2020 | $1,111,000 | – | 44,900 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $50,877,000 | 22.64% |
| Octagon Capital Advisors LP | 2,489,974 | $78,584,000 | 16.99% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $27,451,000 | 8.41% |
| BVF INC/IL | 3,960,948 | $125,008,000 | 5.00% |
| PFM Health Sciences, LP | 3,431,010 | $108,283,000 | 4.05% |
| EcoR1 Capital, LLC | 3,265,101 | $103,047,000 | 3.22% |
| Alphabet Inc. | 2,563,441 | $80,902,000 | 2.62% |
| Boxer Capital, LLC | 1,432,200 | $45,200,000 | 2.32% |
| SECTORAL ASSET MANAGEMENT INC | 338,480 | $10,682,000 | 1.90% |
| PARK CIRCLE Co | 64,000 | $2,020,000 | 1.68% |